Sugar content is a primary concern, especially for patients using these medications for diabetes management
Notably, in March 2024 and August 2025, respectively, resmetirom (an oral, liver-directed thyroid hormone receptor- (THR-)-selective agonist) and subcutaneous semaglutide 2.4 mg/week were granted accelerated approval by the US Food and Drug Administration (FDA) for the treatment of adults with non-cirrhotic MASH and moderate-to-advanced fibrosis in conjunction with lifestyle modification [4]
Standard Glutathione, in particular, is notoriously difficult for the body to absorb in capsule form
Combination trials with GLP-1/GIP agents are in progress, although functional endpoints and long-term safety remain insufficiently defined
Can be combined safely with all Love Wellness products
The selective nature of ipamorelin makes it an excellent foundation for comprehensive peptide therapy protocols designed to enhance overall wellness and vitality